ampicillin has been researched along with Ventilator-Associated Pneumonia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdollahi, A; Beigmohammadi, MT; Doomanlou, M; Khalili, H; Mohammadi, M; Shojaei, L | 1 |
| Assimakopoulos, SF; Christofidou, M; Fligou, F; Gogos, C; Karamouzos, V; Kolonitsiou, F; Lefkaditi, A; Marangos, M; Sklavou, C | 1 |
| Doi, Y; Ernst, RK; Hittle, LE; O'Hara, JA; Pasculle, AW; Qureshi, ZA; Rivera, JI; Shields, RK; Syed, A | 1 |
| Sirvent, JM | 1 |
| Ahern, JW; Aloi, JJ; Bednarik, JL; Crookes, BA; McMillian, WD | 1 |
| Betrosian, AP; Frantzeskaki, F; Georgiadis, G; Xanthaki, A | 1 |
| Betrosian, AP; Douzinas, EE; Frantzeskaki, F; Xanthaki, A | 1 |
3 trial(s) available for ampicillin and Ventilator-Associated Pneumonia
| Article | Year |
|---|---|
Meropenem/colistin versus meropenem/ampicillin-sulbactam in the treatment of carbapenem-resistant pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Ampicillin; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Combinations; Drug Resistance, Bacterial; Female; Humans; Male; Meropenem; Middle Aged; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Sulbactam | 2018 |
High-dose ampicillin-sulbactam as an alternative treatment of late-onset VAP from multidrug-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Ampicillin; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Cross Infection; Disk Diffusion Antimicrobial Tests; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Male; Middle Aged; Pneumonia, Ventilator-Associated; Sulbactam; Treatment Outcome | 2007 |
Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Ampicillin; Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Sulbactam | 2008 |
4 other study(ies) available for ampicillin and Ventilator-Associated Pneumonia
| Article | Year |
|---|---|
Triple combination therapy with high-dose ampicillin/sulbactam, high-dose tigecycline and colistin in the treatment of ventilator-associated pneumonia caused by pan-drug resistant Acinetobacter baumannii: a case series study.
Topics: Acinetobacter baumannii; Administration, Inhalation; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Colistin; Combined Modality Therapy; Drug Resistance, Multiple, Bacterial; Female; Humans; Injections, Intravenous; Intensive Care Units; Male; Middle Aged; Pneumonia, Ventilator-Associated; Retrospective Studies; Sulbactam; Tigecycline | 2019 |
Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Ampicillin; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Electronic Health Records; Electrophoresis, Gel, Pulsed-Field; Ethanolamines; Female; Humans; Lipid A; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Pneumonia, Ventilator-Associated; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Sulbactam | 2015 |
Antibiotic prophylaxis against ventilator-associated pneumonia in patients with coma: Where are we now?
Topics: Ampicillin; Antibiotic Prophylaxis; Brain Injuries, Traumatic; Ceftriaxone; Cefuroxime; Cohort Studies; Coma; Disease Susceptibility; Forecasting; Humans; Pilot Projects; Pneumonia, Ventilator-Associated; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Retrospective Studies; Stroke; Sulbactam | 2017 |
Utility of ampicillin-sulbactam for empiric treatment of ventilator-associated pneumonia in a trauma population.
Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Drug Resistance, Multiple, Bacterial; Female; Guideline Adherence; Haemophilus Infections; Haemophilus influenzae; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcus aureus; Sulbactam; Wounds and Injuries | 2010 |